Approach to hyperkalemia.

dc.contributor.authorLim, Salimen_US
dc.date.accessioned2007-04-16en_US
dc.date.accessioned2009-05-28T04:29:27Z
dc.date.available2007-04-16en_US
dc.date.available2009-05-28T04:29:27Z
dc.date.issued2007-04-16en_US
dc.description17 references.en_US
dc.description.abstractHyperkalemia is commonly found in hospitalized patients. Given the fact that untreated hyperkalemia is associated with high morbidity and mortality, it is critical to recognize and treat this disorder promptly. Patients at greatest risk for hyperkalemia include those with diabetes or impaired renal function, those with advanced age and those receiving drugs which interfere with renal potassium excretion. Hyperkalemia is likely to become an even more common clinical event, since ACE inhibitors, angiotensin-receptor blockers and aldosterone antagonists are increasingly being used in higher doses and in combination, in the belief that these measures provide additional cardiovascular and renal protection. The urgency of hyperkalemia treatment is dictated by change in electrocardiogram. Treatment of hyperkalemia includes calcium gluconate, insulin, beta agonists, sodium bicarbonate, cation exchange resin, diuretics and/or dialysis.en_US
dc.description.affiliationDepartment of Internal Medicine, Medistra Hospital, Jakarta, Indonesia.en_US
dc.identifier.citationLim S. Approach to hyperkalemia. Acta Medica Indonesiana. 2007 Apr-Jun; 39(2): 99-103en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/46957
dc.language.isoengen_US
dc.subject.meshAcidosisen_US
dc.subject.meshHemostasis --drug effectsen_US
dc.subject.meshHumansen_US
dc.subject.meshHyperkalemia --chemically induceden_US
dc.subject.meshPotassium --blooden_US
dc.subject.meshSodium Bicarbonate --therapeutic useen_US
dc.titleApproach to hyperkalemia.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: